Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Superinvestors holding ACAD, Q2 2026
No superinvestor reported holding ACAD in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ACAD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q2 2021
1 superinvestor holding at quarter end